Corient Private Wealth’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Corient Private Wealth's VCYT Position: Q1 2026 in Review
Corient Private Wealth reduced its Veracyte (VCYT) stake by 51% in Q1 2026, selling an estimated $4.9M and leaving 127,722 shares worth $4.11M. The position accounts for 0.01% of the portfolio, ranked #925.
Corient Private Wealth first reported a position in VCYT in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.9M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Corient Private Wealth held 127,722 shares of Veracyte worth $4.11M as of Q1 2026.
- Corient Private Wealth sold 132,352 Veracyte shares in Q1 2026, an estimated $4.9M.
- Veracyte made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #925 holding.
- Corient Private Wealth first reported a position in Veracyte in Q4 2022 and has held it in 13 quarters since.
- Corient Private Wealth's Veracyte position peaked at $10.9M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.